When Bladder Cancer Treatment Strikes Back: Mycotic Aneurysms After Intravesical BCG Therapy
Intravesical Bacillus Calmette-Guerin (BCG) remains the gold standard adjuvant therapy for intermediate and high-risk non-muscle invasive bladder cancer (NMIBC) [...]
Authors
- Sarah B. Blackwell (ORCID: https://orcid.org/0000-0001-6664-5213)
- Kevin Yinkit Zhuo (ORCID: https://orcid.org/0009-0001-2648-319X)
- Balasubramanian Indrajit
- Andrew Jensen
Institutions
- The University of Sydney (AU)
- Royal North Shore Hospital (AU)
- Dubbo Hospital (AU)
Publication Details
- Journal
- Société Internationale d’Urologie Journal
- Published
- 2025-10-20
- DOI
- https://doi.org/10.3390/siuj6050061
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00